1,113
Views
93
CrossRef citations to date
0
Altmetric
Research Article

Novel aspects of wet milling for the production of microsuspensions and nanosuspensions of poorly water-soluble drugs

, , &
Pages 963-976 | Received 08 Oct 2010, Accepted 28 Dec 2010, Published online: 16 Feb 2011

References

  • Muller RH, Peters K. (1998). Nanosuspensions for the formulation of poorly soluble drugs: I. Preparation by a size reduction technique. Int J Pharm, 160:229–237.
  • Noyes A, Whitney W. (1897). The rate of solution of solid substances in their own solutions. J Am Chem Soc, 19:930–934.
  • Florence AT, Attwood D. (1981). Physicochemical Principles of Pharmacy. Chapman and Hall, London.
  • Bisrat M, Nystrom C. (1988). Physicochemical aspects of drug release. VIII. The relation between particle size and surface specific dissolution rate in agitated suspensions. Int J Pharm, 47:223–231.
  • Bilgili E, Hamey R, Scarlett B. (2004). Production of pigment nanoparticles using a wet stirred media mill with polymeric media. China Particuology, 2:93–100.
  • Bilgili E, Hamey R, Scarlett B. (2006). Nano-milling of pigment agglomerates using a wet stirred media mill: Elucidation of the kinetics and breakage mechanisms. Chem Eng Sci, 61:149–157.
  • Ain-Ai A, Gupta PK. (2008). Effect of arginine hydrochloride and hydroxypropyl cellulose as stabilizers on the physical stability of high drug loading nanosuspensions of a poorly soluble compound. Int J Pharm, 351:282–288.
  • Basa S, Muniyappan T, Karatgi P, Prabhu R, Pillai R. (2008). Production and in vitro characterization of solid dosage form incorporating drug nanoparticles. Drug Dev Ind Pharm, 34:1209–1218.
  • Kesisoglou F, Panmai S, Wu Y. (2007). Nanosizing–oral formulation development and biopharmaceutical evaluation. Adv Drug Deliv Rev, 59:631–644.
  • Lee J. (2003). Drug nano- and microparticles processed into solid dosage forms: physical properties. J Pharm Sci, 92:2057–2068.
  • Liversidge GG, Cundy KC. (1995). Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs. Int J Pharm, 125:91–97.
  • Nekkanti V, Pillai R, Venkateshwarlu V, Harisudhan T. (2009). Development and characterization of solid oral dosage form incorporating candesartan nanoparticles. Pharm Dev Technol, 14:290–298.
  • Tanaka Y, Inkyo M, Yumoto R, Nagai J, Takano M, Nagata S. (2009). Nanoparticulation of poorly water soluble drugs using a wet-mill process and physicochemical properties of the nanopowders. Chem Pharm Bull, 57:1050–1057.
  • Bruno JA, Doty BD, Gustow E, Illig KJ, Rajagopalan N, Sarpotdar P. (1996). Method of Grinding Pharmaceutical Substances, US Patent 5518187.
  • Gao L, Zhang D, Chen M, Zheng T, Wang S. (2007). Preparation and characterization of an oridonin nanosuspension for solubility and dissolution velocity enhancement. Drug Dev Ind Pharm, 33:1332–1339.
  • Li X, Gu L, Xu Y, Wang Y. (2009). Preparation of fenofibrate nanosuspension and study of its pharmacokinetic behavior in rats. Drug Dev Ind Pharm, 35:827–833.
  • Kamiya S, Kurita T, Miyagishima A, Arakawa M. (2009). Preparation of griseofulvin nanoparticle suspension by high-pressure homogenization and preservation of the suspension with saccharides and sugar alcohols. Drug Dev Ind Pharm, 35:1022–1028.
  • Mende S, Stenger F, Peukert W, Schwedes J. (2003). Mechanical production and stabilization of submicron particles in stirred media mills. Powder Technol, 132:64–73.
  • Peukert W, Schwarzer H, Stenger F. (2005). Control of aggregation in production and handling of nanoparticles. Chem Eng Process, 44:245–252.
  • Lee J, Lee SJ, Choi JY, Yoo JY, Ahn CH. (2005). Amphiphilic amino acid copolymers as stabilizers for the preparation of nanocrystal dispersion. Eur J Pharm Sci, 24:441–449.
  • Lee J, Choi JY, Park CH. (2008). Characteristics of polymers enabling nano-comminution of water-insoluble drugs. Int J Pharm, 355:328–336.
  • Choi JY, Park CH, Lee J. (2008). Effect of polymer molecular weight on nanocomminution of poorly soluble drug. Drug Deliv, 15:347–353.
  • Choi J-Y, Yoo JY, Kwak H-S, Nam BU, Lee J. (2005). Role of polymeric stabilizers for drug nanocrystal dispersions. Curr Appl Phys, 5:472–474.
  • Van Eerdenbrugh B, Vermant J, Martens JA, Froyen L, Van Humbeeck J, Augustijns P et al. (2009). A screening study of surface stabilization during the production of drug nanocrystals. J Pharm Sci, 98:2091–2103.
  • Liversidge GG, Conzentino P. (1995). Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats. Int J Pharm, 125:309–313.
  • Van Eerdenbrugh B, Van den Mooter G, Augustijns P. (2008). Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products. Int J Pharm, 364:64–75.
  • Deng Z, Xu S, Li S. (2008). Understanding a relaxation behavior in a nanoparticle suspension for drug delivery applications. Int J Pharm, 351:236–243.
  • Butyagin P. (1999). Rehbinder’s predictions and advances in mechanochemistry. Colloids Surf A 160:107–115.
  • El-Shall H, Somasundaran P. (1984). Physico-chemical aspects of grinding: a review of use of additives. Powder Technol, 38:275–293.
  • Rehbinder PA, Shchukin ED. (1972). Surface phenomena in solids during deformation and fracture processes. Prog Surf Sci, 3:97–104.
  • Shchukin ED. (1999). Physical–chemical mechanics in the studies of Peter A. Rehbinder and his school Colloids Surf A, 149:529–537.
  • Shchukin ED. (2006). The influence of surface-active media on the mechanical properties of materials. Adv Colloid Interface Sci, 123-126:33–47.
  • Dalvi SV, Dave RN. (2010). Analysis of nucleation kinetics of poorly water-soluble drugs in presence of ultrasound and hydroxypropyl methyl cellulose during antisolvent precipitation. Int J Pharm, 387:172–179.
  • Larsson I, Kristensen HG. (2000). Comminution of a brittle/ductile material in a Micros Ring Mill. Powder Technol, 107:175–178.
  • Eskin D, Zhupanska O, Hamey R, Moudgil B, Scarlett B. (2005). Microhydrodynamics of stirred media milling. Powder Technol, 156:95–102.
  • Merisko-Liversidge E, Liversidge GG, Cooper ER. (2003). Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur J Pharm Sci, 18:113–120.
  • Ploehn HJ, Russel WB. (1990). Interactions between colloidal particles and soluble polymers. Adv Chem Eng, 15:137–228.
  • Zimmermann E, Müller RH. (2001). Electrolyte- and pH-stabilities of aqueous solid lipid nanoparticle (SLN) dispersions in artificial gastrointestinal media. Eur J Pharm Biopharm, 52:203–210.
  • Klimpel RR. (1997). Introduction to the Principles of Size Reduction of Particles by Mechanical Means, Instructional Module Series, NSF ERC of U. Florida.
  • Liu Y, Kathan K, Saad W, Prud’homme RK. (2007). Ostwald ripening of beta-carotene nanoparticles. Phys Rev Lett, 98:036102.
  • Kwade A, Blecher L, Schwedes J. (1996). Motion and stress intensity of grinding beads in a stirred media mill. Part 2: Stress intensity and its effect on comminution. Powder Technol, 86:69–76.
  • Hu J, Johnston KP, Williams RO 3rd. (2004). Nanoparticle engineering processes for enhancing the dissolution rates of poorly water soluble drugs. Drug Dev Ind Pharm, 30:233–245.
  • Park CH, Youn HR, Lee J, Lee KU, Park JY, Koh EH et al. (2009). Improved efficacy of appetite suppression by lipoic acid particles prepared by nanocomminution. Drug Dev Ind Pharm, 35:1305–1311.
  • Sigfridsson K, Forssén S, Holländer P, Skantze U, de Verdier J. (2007). A formulation comparison, using a solution and different nanosuspensions of a poorly soluble compound. Eur J Pharm Biopharm, 67:540–547.
  • Sigfridsson K, Lundqvist AJ, Strimfors M. (2009). Particle size reduction for improvement of oral absorption of the poorly soluble drug UG558 in rats during early development. Drug Dev Ind Pharm, 35:1479–1486.
  • Zhang L, Chai G, Zeng X, He H, Xu H, Tang X. (2010). Preparation of fenofibrate immediate-release tablets involving wet grinding for improved bioavailability. Drug Dev Ind Pharm, 36:1054–1063.
  • Date AA, Patravale VB. (2004). Current strategies for engineering drug nanoparticles. Curr Opin Colloid Interface Sci, 9:222–235.
  • Ostrander KD, Bosch HW, Bondanza DM. (1999). An in-vitro assessment of a NanoCrystal beclomethasone dipropionate colloidal dispersion via ultrasonic nebulization. Eur J Pharm Biopharm, 48:207–215.
  • Karpenko GV. (1974). The 45th anniversary of the Rehbinder effect. Fiziko-Khimicheskaya Mekhanika Materialov, 10:5–7.
  • Hanna KM, Gamal AE. (1977). Effect of dispersing agents on fine grinding of Limestone. Powder Technol, 17:19–25.
  • Klimpel RR, Manfroy W. (1978). Chemical grinding aids for increasing throughput in the wet grinding of ores. Ind Eng Chem Process Des Dev, 17:518–523.
  • Klimpel RR, Austin LG. (1982). Chemical additives for wet grinding of minerals. Powder Technol, 31:239–253.
  • Klimpel R. (1982). Laboratory studies of the grinding and rheology of coal-water slurries. Powder Technol, 32:267–277.
  • He M, Wang Y, Frossberg E. (2004). Slurry rheology in wet ultrafine grinding of industrial minerals: a review. Powder Technol, 147:94–112.
  • Higaki K, Kimura T. (2008). In vitro–in vivo correlation for wet-milled tablet of poorly water-soluble cilostazol. J Controlled Release, 130:29–37.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.